RU2416618C2 - Соединения, представляющие собой пептидные аналоги стимуляторов секреции гормона роста, и содержащие их препараты - Google Patents
Соединения, представляющие собой пептидные аналоги стимуляторов секреции гормона роста, и содержащие их препараты Download PDFInfo
- Publication number
- RU2416618C2 RU2416618C2 RU2008138569/10A RU2008138569A RU2416618C2 RU 2416618 C2 RU2416618 C2 RU 2416618C2 RU 2008138569/10 A RU2008138569/10 A RU 2008138569/10A RU 2008138569 A RU2008138569 A RU 2008138569A RU 2416618 C2 RU2416618 C2 RU 2416618C2
- Authority
- RU
- Russia
- Prior art keywords
- ghrelin
- ghs
- compounds
- growth hormone
- peptide
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20060050A CU23558A1 (es) | 2006-02-28 | 2006-02-28 | Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento |
| CU2006-0050 | 2006-02-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2008138569A RU2008138569A (ru) | 2010-04-10 |
| RU2416618C2 true RU2416618C2 (ru) | 2011-04-20 |
Family
ID=40130780
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2008138569/10A RU2416618C2 (ru) | 2006-02-28 | 2007-02-28 | Соединения, представляющие собой пептидные аналоги стимуляторов секреции гормона роста, и содержащие их препараты |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8367620B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1997827B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5183496B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101409277B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101432294B (cg-RX-API-DMAC7.html) |
| AR (1) | AR059646A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007219569B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0708366A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2637593C (cg-RX-API-DMAC7.html) |
| CL (2) | CL2007000528A1 (cg-RX-API-DMAC7.html) |
| CU (1) | CU23558A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2441441T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2008011142A (cg-RX-API-DMAC7.html) |
| MY (1) | MY184130A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20084118L (cg-RX-API-DMAC7.html) |
| RU (1) | RU2416618C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007098716A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200807162B (cg-RX-API-DMAC7.html) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2734835C1 (ru) * | 2020-02-11 | 2020-10-23 | Федеральное государственное бюджетное учреждение науки Лимнологический институт Сибирского отделение Российской академии наук (ЛИН СО РАН) | Способ повышения жизнестойкости эмбрионов рыб в аквакультуре |
| RU2768134C2 (ru) * | 2016-11-01 | 2022-03-23 | Сентро Де Инхеньерия Хенетика И Биотекнолохия | Применение пептида, усиливающего секрецию соматотропного гормона, в качестве адъюванта вакцины |
| RU2779835C1 (ru) * | 2018-08-21 | 2022-09-13 | Сентро Де Инхеньерия Хенетика И Биотекнолохия | Применение ghrp-6 в качестве кардиозащитного и кардиовосстанавливающего лекарственного средства для позднего лечения |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4831551B2 (ja) * | 2008-11-06 | 2011-12-07 | 国立大学法人名古屋大学 | 非虚血性心筋障害に対する医薬 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6849597B2 (en) * | 1999-12-28 | 2005-02-01 | Kaken Pharmaceutical Co., Ltd. | Neuroprotective drug |
| US6939880B2 (en) * | 1995-12-22 | 2005-09-06 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
Family Cites Families (90)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3239345A (en) | 1965-02-15 | 1966-03-08 | Estrogenic compounds and animal growth promoters | |
| US4411890A (en) | 1981-04-14 | 1983-10-25 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4036979A (en) | 1974-01-25 | 1977-07-19 | American Cyanamid Company | Compositions containing 4,5,6,7-tetrahydrobenz[b]thien-4-yl-ureas or derivatives and methods of enhancing growth rate |
| AU628322B2 (en) | 1988-01-28 | 1992-09-17 | Eastman Kodak Company | Polypeptide compounds having growth hormone releasing activity |
| AU637316B2 (en) | 1988-01-28 | 1993-05-27 | Eastman Kodak Company | Polypeptide compounds having growth hormone releasing activity |
| JP2670680B2 (ja) | 1988-02-24 | 1997-10-29 | 株式会社ビーエムジー | 生理活性物質含有ポリ乳酸系微小球およびその製造法 |
| DK0554381T3 (da) | 1990-10-25 | 1996-04-09 | Genentech Inc | Anvendelse af beskyttende midler mod reaktive oxygenforbindelser |
| US5663146A (en) | 1991-08-22 | 1997-09-02 | Administrators Of The Tulane Educational Fund | Polypeptide analogues having growth hormone releasing activity |
| CA2147503A1 (en) | 1992-11-06 | 1994-05-26 | Judith M. Pisano | Substituted dipeptide analogs promote release of growth hormone |
| US5726319A (en) | 1992-11-06 | 1998-03-10 | Merck & Co., Inc. | Biphenyl substituted dipeptide analogs promote release of growth hormone |
| US5578593A (en) | 1992-12-11 | 1996-11-26 | Merck & Co., Inc. | Spiro piperidines and homologs promote release of growth hormone |
| SK282166B6 (sk) | 1992-12-11 | 2001-11-06 | Merck & Co., Inc. | Spiropiperidínové deriváty, spôsob ich výroby a farmaceutický prostriedok s ich obsahom |
| AU8083694A (en) | 1993-10-19 | 1995-05-08 | Merck & Co., Inc. | Combination of bisphosphonates and growth hormone secretagogues |
| US5492916A (en) | 1993-12-23 | 1996-02-20 | Merck & Co., Inc. | Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
| US5494919A (en) | 1993-11-09 | 1996-02-27 | Merck & Co., Inc. | 2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
| BR9408019A (pt) | 1993-11-09 | 1997-08-26 | Merck & Co Inc | Composto composição util para aumentar a produção endógena ou a liberaçao de hormonio do crescimento em ser humano ou um animal e para o tratamento da osteoporose processos para aumentar os niveis de hormônio do crescimento em um ser humano ou um animal e a eficácia de alimentação promover o crescimento aumentar a produçao de leite e melhorar a qualidade da carcaça de gado para tratar ou previnir uma condição selecionada para tratar osteoporose e para preparar um composto |
| WO1995014666A1 (en) | 1993-11-24 | 1995-06-01 | Merck & Co., Inc. | Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s) |
| US5721251A (en) | 1993-12-10 | 1998-02-24 | Merck & Co., Inc. | Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone |
| US5854211A (en) | 1993-12-23 | 1998-12-29 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| CA2179597A1 (en) | 1993-12-23 | 1995-06-29 | Nils Langeland Johansen | Compounds with growth hormone releasing properties |
| US5721250A (en) | 1993-12-23 | 1998-02-24 | Merck & Co. Inc. | Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
| US5777112A (en) | 1994-06-13 | 1998-07-07 | Merck & Co., Inc | Piperazine compounds promote release of growth hormone |
| WO1996002530A1 (en) | 1994-07-20 | 1996-02-01 | Merck & Co., Inc. | Piperidines and hexahydro-1h-azepines spiro substituted at the 4-position promote release of growth hormone |
| US5798337A (en) | 1994-11-16 | 1998-08-25 | Genentech, Inc. | Low molecular weight peptidomimetic growth hormone secretagogues |
| WO1996022996A1 (en) | 1995-01-25 | 1996-08-01 | Nippon Chemiphar Co., Ltd. | Dihydrophenazine derivatives |
| MY113488A (en) | 1995-01-27 | 2002-03-30 | Novo Nordisk As | Compounds with growth hormone releasing properties |
| AU4534596A (en) | 1995-02-09 | 1996-08-27 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| AU4534696A (en) | 1995-02-09 | 1996-08-27 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| US5559128A (en) | 1995-04-18 | 1996-09-24 | Merck & Co., Inc. | 3-substituted piperidines promote release of growth hormone |
| AU5486396A (en) | 1995-04-19 | 1996-11-07 | Merck & Co., Inc. | Process for the preparation of spiroindolines |
| WO1996035713A1 (en) | 1995-05-08 | 1996-11-14 | Pfizer, Inc. | Dipeptides which promote release of growth hormone |
| JP3133073B2 (ja) | 1995-05-29 | 2001-02-05 | ファイザー・インコーポレーテッド | 成長ホルモンの放出を促進するジペプチド類 |
| HUP9802821A3 (en) | 1995-06-22 | 2000-03-28 | Novo Nordisk As | Compounds with growth hormone releasing properties |
| AU6772996A (en) | 1995-08-21 | 1997-03-12 | Eli Lilly And Company | 2-acylaminopropanamides as growth hormone secretagogues |
| WO1997007117A1 (en) | 1995-08-21 | 1997-02-27 | Eli Lilly And Company | 2-acylaminopropanamines as growth hormone secretagogues |
| EP0766966A3 (en) | 1995-09-08 | 2001-02-28 | Eli Lilly And Company | Method of treating insulin resistance |
| AU7169696A (en) | 1995-09-26 | 1997-04-17 | Merck & Co., Inc. | 3-spirolactam, 3-spiroamino, 3-spirolactone and 3-spirobenzopyran piperidines and pyrrolidines promote release of growth hormone |
| US5723616A (en) | 1995-10-27 | 1998-03-03 | Merck & Co., Inc. | Process for the preparation of a growth hormone secretagogue |
| US5767124A (en) | 1995-10-27 | 1998-06-16 | Merck & Co., Inc. | Polymorphic forms of a growth hormone secretagogue |
| JPH11513989A (ja) | 1995-10-27 | 1999-11-30 | メルク エンド カンパニー インコーポレーテッド | 成長ホルモン分泌促進薬の湿式造粒製剤 |
| BR9610887A (pt) | 1995-10-27 | 1999-07-13 | Merck & Co Inc | Processo para a preparação de um composto |
| ES2229289T3 (es) | 1995-12-13 | 2005-04-16 | MERCK & CO., INC. | Familia de receptores de secretagogo de la hormona del crecimiento. |
| WO1997022004A1 (en) | 1995-12-13 | 1997-06-19 | Merck & Co., Inc. | Assays for growth hormone secretagogue receptors |
| IT1277113B1 (it) | 1995-12-20 | 1997-11-04 | Romano Deghenghi | Composti oligopeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della crescita |
| WO1997022367A1 (en) | 1995-12-20 | 1997-06-26 | Merck & Co., Inc. | Radiolabeled growth hormone secretagogue |
| TW432073B (en) | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
| AU2334097A (en) | 1996-03-21 | 1997-10-10 | Merck & Co., Inc. | 4-spiroindoline piperidines promote release of growth hormone |
| AU2722297A (en) | 1996-04-03 | 1997-10-22 | Merck & Co., Inc. | Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone |
| SE9601397D0 (sv) | 1996-04-12 | 1996-04-12 | Pharmacia Ab | Use of growth hormone |
| AU2382097A (en) | 1996-04-19 | 1997-11-12 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| US5919777A (en) | 1996-04-24 | 1999-07-06 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| WO1997040023A1 (en) | 1996-04-24 | 1997-10-30 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| AU711884B2 (en) | 1996-05-07 | 1999-10-21 | Merck & Co., Inc. | Enhancement of sleep with a growth hormone secretagogue |
| WO1997041878A1 (en) | 1996-05-07 | 1997-11-13 | Merck & Co., Inc. | Treatment of mood disorders with a growth hormone secretagogue |
| AU2764797A (en) | 1996-05-14 | 1997-12-05 | Novo Nordisk A/S | Somatostatin agonists and antagonists |
| WO1997044042A1 (en) | 1996-05-22 | 1997-11-27 | Arch Development Corporation | Sleep quality improvement using a growth hormone secretagogue |
| JP2000512274A (ja) | 1996-05-31 | 2000-09-19 | ノボ ノルディスク アクティ―ゼルスカブ | 骨粗しょう症の周期的(整合性)治療における成長ホルモン成分及び骨抗吸収剤 |
| EP1184370B1 (en) | 1996-07-22 | 2005-09-14 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| WO1998010653A1 (en) | 1996-09-13 | 1998-03-19 | Merck & Co., Inc. | Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone |
| WO1998018815A1 (en) | 1996-10-25 | 1998-05-07 | Merck & Co., Inc. | Convergent process for the preparation of a growth hormone secretagogue |
| SE9703929D0 (sv) | 1996-11-22 | 1997-10-28 | Pharmacia & Upjohn Ab | Therapeutical use and method |
| WO1998046569A1 (fr) | 1997-04-11 | 1998-10-22 | Sumitomo Pharmaceuticals Co., Ltd. | Derives de benzene |
| JP2000514838A (ja) | 1997-05-14 | 2000-11-07 | 藤沢薬品工業株式会社 | 成長ホルモンの放出を促進するピペリジノ誘導体 |
| US5861149A (en) | 1997-06-04 | 1999-01-19 | Polyheal Ltd. | Methods for wound treatment |
| WO1998058950A1 (en) | 1997-06-20 | 1998-12-30 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| UA64751C2 (uk) | 1997-06-25 | 2004-03-15 | Пфайзер Продактс Інк. | Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти) |
| UA53716C2 (uk) | 1997-06-25 | 2003-02-17 | Пфайзер Продактс Інк. | Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти) |
| US6251902B1 (en) | 1997-06-25 | 2001-06-26 | Pfizer Inc. | Dipeptide derivatives as growth hormone secretagogues |
| ZA987383B (en) | 1997-08-19 | 2000-02-17 | Lilly Co Eli | Treatment of congestive heart failure with growth hormone secretagogues. |
| AU758160B2 (en) | 1997-08-22 | 2003-03-20 | Kaken Pharmaceutical Co., Ltd. | Novel amide derivatives |
| IL137007A0 (en) | 1998-01-16 | 2001-06-14 | Novo Nordisk As | Compounds with growth hormone releasing properties |
| WO1999039730A1 (en) | 1998-02-09 | 1999-08-12 | Kaken Pharmaceutical Co., Ltd. | Oral preparations containing peptides promoting the secretion of growth hormone |
| KR20010041533A (ko) | 1998-03-03 | 2001-05-25 | 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 | (2e)-5-아미노-5-메틸헥스-2-엔오산n-메틸-n-((1r)-1-(n-메틸-n-((1r)-1-(메틸카르바모일)-2-페닐에틸)카르바모일)-2-(2-나프틸)에틸)아미드의신규한 염 형태 |
| CZ301276B6 (cs) | 1998-05-11 | 2009-12-30 | Novo Nordisk A/S | Piperidinový derivát vykazující schopnost uvolnování rustového hormonu |
| WO1999064456A1 (en) | 1998-06-09 | 1999-12-16 | Novo Nordisk A/S | A method for preparing a compound with growth hormone releasing properties |
| AP9901582A0 (en) | 1998-06-16 | 1999-06-30 | Pfizer Prod Inc | Combination therapy for musculoskeletal frailty. |
| AU3342099A (en) | 1998-06-16 | 2000-01-05 | Pfizer Products Inc. | Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty |
| CN1304424C (zh) | 1998-06-30 | 2007-03-14 | 诺沃挪第克公司 | 具有生长激素释放特性的化合物 |
| CN1161333C (zh) | 1998-08-20 | 2004-08-11 | 住友制药株式会社 | 作为生长激素释放剂的2-羟基吲哚衍生物 |
| US6358951B1 (en) | 1998-08-21 | 2002-03-19 | Pfizer Inc. | Growth hormone secretagogues |
| CA2411667A1 (en) | 2000-05-30 | 2001-12-06 | Merck & Co. Inc. | Ghrelin analogs |
| ATE446758T1 (de) | 2000-05-31 | 2009-11-15 | Pfizer Prod Inc | Verwendung von wachstumshormonsekretagoga zur förderung der beweglichkeit des verdauungstrakts |
| ATE302181T1 (de) | 2000-06-13 | 2005-09-15 | Zentaris Gmbh | Verbindungen zur stimulation der sekretion von wachstumshormonen |
| AU2001274601A1 (en) | 2000-06-23 | 2002-01-02 | Kaken Pharmaceutical Co., Ltd. | Preventives or remedies for heart failure |
| ITMI20011445A1 (it) | 2001-07-06 | 2003-01-06 | Europ Geie | Analoghi della cortistantina capaci di legarsi selettivamente ai recettori dei secretagoghi dell'ormone della crescita |
| CU23043A1 (es) | 2001-12-20 | 2005-05-20 | Ct Ingenieria Genetica Biotech | Composicion farmaceutica que contiene factor de crecimiento epidrmico (egf) para la prevencion de la amputacion de pie diabetico. |
| US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
| WO2005039625A1 (en) | 2003-10-28 | 2005-05-06 | Rheoscience A/S | Growth hormone secretagogue receptor agonists |
| US7504506B2 (en) | 2003-11-04 | 2009-03-17 | Elixir Pharmaceuticals, Inc. | Therapeutic compounds and uses thereof |
| WO2005048916A2 (en) | 2003-11-20 | 2005-06-02 | Biovitrum Ab | Tetrahydrospiro-beta-carboline-1,3 '-pyrrolidine derivatives and their use in ghsr-related disorders |
-
2006
- 2006-02-28 CU CU20060050A patent/CU23558A1/es active IP Right Grant
-
2007
- 2007-02-27 AR ARP070100806A patent/AR059646A1/es not_active Application Discontinuation
- 2007-02-27 CL CL2007000528A patent/CL2007000528A1/es unknown
- 2007-02-28 CA CA2637593A patent/CA2637593C/en not_active Expired - Fee Related
- 2007-02-28 RU RU2008138569/10A patent/RU2416618C2/ru not_active IP Right Cessation
- 2007-02-28 US US12/281,085 patent/US8367620B2/en not_active Expired - Fee Related
- 2007-02-28 MY MYPI20083178A patent/MY184130A/en unknown
- 2007-02-28 EP EP07711101.1A patent/EP1997827B1/en not_active Not-in-force
- 2007-02-28 WO PCT/CU2007/000007 patent/WO2007098716A1/es not_active Ceased
- 2007-02-28 KR KR1020087023543A patent/KR101409277B1/ko not_active Expired - Fee Related
- 2007-02-28 BR BRPI0708366-1A patent/BRPI0708366A2/pt not_active IP Right Cessation
- 2007-02-28 CN CN2007800153594A patent/CN101432294B/zh not_active Expired - Fee Related
- 2007-02-28 ES ES07711101.1T patent/ES2441441T3/es active Active
- 2007-02-28 MX MX2008011142A patent/MX2008011142A/es active IP Right Grant
- 2007-02-28 JP JP2008556643A patent/JP5183496B2/ja not_active Expired - Fee Related
- 2007-02-28 AU AU2007219569A patent/AU2007219569B2/en not_active Ceased
-
2008
- 2008-08-19 ZA ZA200807162A patent/ZA200807162B/xx unknown
- 2008-09-29 NO NO20084118A patent/NO20084118L/no not_active Application Discontinuation
-
2016
- 2016-06-24 CL CL2016001648A patent/CL2016001648A1/es unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6939880B2 (en) * | 1995-12-22 | 2005-09-06 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| US6849597B2 (en) * | 1999-12-28 | 2005-02-01 | Kaken Pharmaceutical Co., Ltd. | Neuroprotective drug |
Non-Patent Citations (1)
| Title |
|---|
| CORT J.H. et al. Regional and systemic haemodynamic effects of some vasopressin, Europ. J. Clin. Invest., 1975, 5, 165-175. LAMMEK В. et al. Synthesis of three NH2-terminally extended arginine vasopressin with prolonged biological activities, Experentia, 1987, 43, 1211-1212. ШУНДЕРОВИЧ М.Д. и др. Исследование пространственной структуры des-Gly9-[Arg8]вазопрессина методами двумерной спектроскопии ЯМР и теоретического конформационного анализа, Биоорганическая химия, 1985, 11 (9), 1180-1191. * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2768134C2 (ru) * | 2016-11-01 | 2022-03-23 | Сентро Де Инхеньерия Хенетика И Биотекнолохия | Применение пептида, усиливающего секрецию соматотропного гормона, в качестве адъюванта вакцины |
| RU2779835C1 (ru) * | 2018-08-21 | 2022-09-13 | Сентро Де Инхеньерия Хенетика И Биотекнолохия | Применение ghrp-6 в качестве кардиозащитного и кардиовосстанавливающего лекарственного средства для позднего лечения |
| RU2734835C1 (ru) * | 2020-02-11 | 2020-10-23 | Федеральное государственное бюджетное учреждение науки Лимнологический институт Сибирского отделение Российской академии наук (ЛИН СО РАН) | Способ повышения жизнестойкости эмбрионов рыб в аквакультуре |
Also Published As
| Publication number | Publication date |
|---|---|
| MX2008011142A (es) | 2008-09-08 |
| CN101432294B (zh) | 2013-09-11 |
| EP1997827A1 (en) | 2008-12-03 |
| JP5183496B2 (ja) | 2013-04-17 |
| WO2007098716A8 (es) | 2008-12-18 |
| CU23558A1 (es) | 2010-07-20 |
| ES2441441T3 (es) | 2014-02-04 |
| JP2009528303A (ja) | 2009-08-06 |
| RU2008138569A (ru) | 2010-04-10 |
| US8367620B2 (en) | 2013-02-05 |
| MY184130A (en) | 2021-03-19 |
| ZA200807162B (en) | 2009-06-24 |
| CN101432294A (zh) | 2009-05-13 |
| KR101409277B1 (ko) | 2014-06-24 |
| NO20084118L (no) | 2008-09-29 |
| US20100055118A1 (en) | 2010-03-04 |
| CA2637593C (en) | 2015-04-14 |
| CL2007000528A1 (es) | 2008-01-18 |
| CA2637593A1 (en) | 2007-09-07 |
| BRPI0708366A2 (pt) | 2011-05-24 |
| WO2007098716A1 (es) | 2007-09-07 |
| CL2016001648A1 (es) | 2017-02-24 |
| AU2007219569B2 (en) | 2012-03-15 |
| EP1997827B1 (en) | 2013-10-09 |
| AU2007219569A1 (en) | 2007-09-07 |
| AR059646A1 (es) | 2008-04-16 |
| KR20080110763A (ko) | 2008-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Muccioli et al. | Heterogeneity of ghrelin/growth hormone secretagogue receptors: toward the understanding of the molecular identity of novel ghrelin/GHS receptors | |
| Smith | Development of growth hormone secretagogues | |
| KR20160142322A (ko) | 펩티드 이중 glp-1/글루카곤 수용체 효능제로서의 엑센딘-4 유도체 | |
| EP2272524A2 (en) | Y2 selective receptor agonists for therapeutic interventions | |
| ES2818556T3 (es) | Péptido con eficacia antiobesidad y antidiabética y uso del mismo | |
| Ringuet et al. | G protein‐coupled receptor interactions and modification of signalling involving the ghrelin receptor, GHSR1a | |
| Vodnik et al. | Ghrelin receptor ligands reaching clinical trials: from peptides to peptidomimetics; from agonists to antagonists | |
| CN100425282C (zh) | 用于治疗性干预的y2/y4选择性受体激动剂 | |
| Wan et al. | Characterization of neuromedin U (NMU), neuromedin S (NMS) and their receptors (NMUR1, NMUR2) in chickens | |
| Eliakim et al. | Exercise, training, and the GH-IGF-I axis | |
| Gonzalez et al. | Pituitary adenylate cyclase-activating polypeptide | |
| US20240279278A1 (en) | Nmu receptor 2 agonists | |
| Masuda et al. | PEGylated neuromedin U-8 shows long-lasting anorectic activity and anti-obesity effect in mice by peripheral administration | |
| US8367620B2 (en) | Peptidic growth hormone secretagogues analog compounds and preparations thereof | |
| Goetze et al. | Procholecystokinin expression and processing in cardiac myocytes | |
| Fang et al. | Cardiovascular effects of intravenous administered 26RFa, a novel RFamide peptide ligand for GPR103, in anaesthetised rats | |
| KR101920047B1 (ko) | 항비만 및 항당뇨 효능을 갖는 펩타이드 및 이의 용도 | |
| Muccioli et al. | Known and unknown growth hormone secretagogue receptors and their ligands | |
| Kojima et al. | Discovery of Ghrelin, an Endogenous Ligand for the Growth-Hormone Secret Agogue Receptor | |
| KOJIMA et al. | Ghrelin, an Endogenous Ligand for the Growth Hormone Secretagogue Receptor | |
| Soll et al. | On the role of neuropeptides in the hypothalamic regulation of food intake | |
| Kojima et al. | Screening and Identification of Ghrelin, an Endogenous Ligand for GHS-R |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20180301 |